GT Biopharma (GTBP) Share-based Compensation (IS) (2021 - 2025)
GT Biopharma's Share-based Compensation (IS) was $46,000 in Q4 2025, up 475.0% from $8,000 a year earlier but down 87.9% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Share-based Compensation (IS) (2021 - 2025) Analysis & Trends
For FY2025, Share-based Compensation (IS) at GT Biopharma came in at $432,000, up 87.8% from FY2024.
- Share-based Compensation (IS) shows a four-year compound annual growth rate of -60.2% (FY2021 to FY2025).
- In earlier years, Share-based Compensation (IS) was $230,000 in FY2024 (-89.6%), $2.22 million in FY2023 (-43.1%), $3.9 million in FY2022 (-77.4%) and $17.23 million in FY2021.
- Quarterly Share-based Compensation (IS) has moved between $3,000 (Q1 2025) and $14.3 million (Q1 2021) over five years.
- Compared with a year earlier, Share-based Compensation (IS) was higher in 1 of the last six quarters, with growth averaging 4.6%.
- The best year-over-year quarter for Share-based Compensation (IS) over five years was Q4 2025 (growth of 475.0%); the worst was Q4 2024 (a decline of 98.2%).
- Per Business Quant data, GTBP's Share-based Compensation (IS) in the three quarters before Q4 2025 was $379,000 (Q3 2025), $4,000 (Q2 2025) and $3,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | - |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | 379,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Dec 31, 2023 | 453,000.00 |
| Sep 30, 2023 | 547,000.00 |
| Jun 30, 2023 | 398,000.00 |
| Mar 31, 2023 | 718,000.00 |
| Dec 31, 2022 | 403,000.00 |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 463,000.00 |
| Mar 31, 2022 | 447,000.00 |
| Dec 31, 2021 | 1.78 Mn |
| Sep 30, 2021 | 577,000.00 |
| Jun 30, 2021 | 577,000.00 |
| Mar 31, 2021 | 14.30 Mn |
API Access
GT Biopharma Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();